Latest Share Chat

REMOVE ADS

MTPH.L Share News (MTPH)

MTPH.L Information

There is currently no data for MTPH

REMOVE ADS

IN BRIEF: Midatech Pharma Terminates Formal Sales Process

Fri, 24th Jul 2020 17:24

Midatech Pharma PLC - drug delivery company - Terminates formal sales process which kicked off in April. Currently evaluating proposals from third parties, including for the potential acquisition of some company assets which would count as a reverse takeover.

Current stock price: 39.50 pence

Year-to-date change: down 29%

By Eric Cunha; ericcunha@alliancenews.com

Latest MTPH News

IN BRIEF: Midatech Pharma delisting and name change approved
24 Mar 2023
UK shareholder meetings calendar - next 7 days
17 Mar 2023
Midatech Pharma shares up as closed USD6.0 million private placement
15 Feb 2023
IN BRIEF: Midatech Pharma raises USD6.0 million for clinical asset
9 Feb 2023
Midatech's Nasdaq price falls below minimum of USD1.00 per share
3 Feb 2023
UK shareholder meetings calendar - next 7 days
16 Jan 2023
TRADING UPDATES: Alliance Pharma hires COO; Empire advances field work
12 Jan 2023
TRADING UPDATES: Gulf Keystone chair to retire; JZ Capital cashes in
19 Dec 2022

MTPH.L News

IN BRIEF: Midatech Pharma delisting and name change approved

Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Says resolutio...

UK shareholder meetings calendar - next 7 days

Midatech Pharma shares up as closed USD6.0 million private placement

(Alliance News) - Midatech Pharma PLC on Wednesday said it has raised USD6.0 million through a private placement of 10.3 million shares at USD0.58 eac...

IN BRIEF: Midatech Pharma raises USD6.0 million for clinical asset

Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Raises gross p...

Midatech's Nasdaq price falls below minimum of USD1.00 per share

(Alliance News) - Midatech Pharma PLC on Friday said it received notice that its share price has fallen short of the minimum needed according to Nasda...